Bellevue Healthcare Trust plc
BBH.L · LSE
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Revenue | -£149,927 | £43,449 | £105,743 | £170,470 |
| % Growth | -445.1% | -58.9% | -38% | – |
| Cost of Goods Sold | £6,493 | £8,003 | £9,594 | £9,892 |
| Gross Profit | -£156,420 | £35,446 | £96,149 | £160,578 |
| % Margin | 104.3% | 81.6% | 90.9% | 94.2% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £1,135 | £1,090 | £1,069 | £1,178 |
| SG&A Expenses | £1,135 | £1,090 | £1,069 | £1,224 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £46 |
| Other Operating Expenses | £25 | £537 | £64 | £20 |
| Operating Expenses | £1,160 | £1,627 | £1,133 | £1,244 |
| Operating Income | £76,924 | -£116,042 | -£28,250 | £92,223 |
| % Margin | -51.3% | -267.1% | -26.7% | 54.1% |
| Other Income/Exp. Net | -£3,077 | -£4,839 | -£12,889 | -£4,314 |
| Pre-Tax Income | £73,847 | -£120,881 | -£41,139 | £87,909 |
| Tax Expense | £113 | £157 | £285 | £659 |
| Net Income | £73,734 | -£121,038 | -£41,424 | £87,250 |
| % Margin | -49.2% | -278.6% | -39.2% | 51.2% |
| EPS | 0.16 | -0.22 | -0.091 | 0.17 |
| % Growth | 172.7% | -141.5% | -153.6% | – |
| EPS Diluted | 0.16 | -0.22 | -0.091 | 0.17 |
| Weighted Avg Shares Out | 458,515 | 548,691 | 454,706 | 509,593 |
| Weighted Avg Shares Out Dil | 458,515 | 548,691 | 454,706 | 509,593 |
| Supplemental Information | – | – | – | – |
| Interest Income | £2,275 | £1,547 | £283 | £0 |
| Interest Expense | £1,811 | £3,513 | £2,986 | £489 |
| Depreciation & Amortization | £0 | £0 | £0 | £237 |
| EBITDA | £76,924 | -£116,042 | -£28,250 | £92,223 |
| % Margin | -51.3% | -267.1% | -26.7% | 54.1% |